In today’s senate hearing, the lobbyist representing compounding pharmacies said the company was operating as a rogue drug manufacturer and should have been shut down years ago by state or federal regulators.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help